Clinical Trials Directory

Trials / Completed

CompletedNCT01395550

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Status
Completed
Phase
—
Study type
Observational
Enrollment
88 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2011-07-15
Last updated
2011-08-30

Source: ClinicalTrials.gov record NCT01395550. Inclusion in this directory is not an endorsement.

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event (NCT01395550) · Clinical Trials Directory